Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer

Endocrine Journal

Volumn 44, Issue 3, 1997, Pages 419-424

  Ayabe, Takuya ^a   Tsutsumi, Osamu ^a   Sakai, Hideaki ^a   Yoshikawa, Hirovuki ^a   Yano, Tetsu ^a   Kurimoto, Fumihiko ^b   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Endometrial cancer; Insulin like growth factor binding protein 1; Insulin like growth factor I

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RISK; CLINICAL ARTICLE; ENDOMETRIUM; ENDOMETRIUM CANCER; FEMALE; HUMAN; MITOGENESIS; POSTMENOPAUSE;

EID: 0030843850     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.44.419     Document Type: Article

References (22)

1. Seppälä M, Koistinen R, Rutanen E-M (1994) Uterine endocrinology and paracrinology: Insulin-like growth factor binding protein-1 and placental protein 14 revisited. Hum Reprod 9: 917-925.
2. Talavera F, Reynolds RK, Roberts JA, Menon KMJ (1990) Insulin-like growth factor I receptors in normal and neoplastic human endometrium. Cancer Res 50: 3019-3024.
3. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: Biological actions. Endocrine Rev 16: 3-34.
4. Koistinen R, Huhtala M-L, Stenman U-H, Seppala M (1987) Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding proteins. Clin Chim Acta 164: 293-303.
5. Rutanen E-M, Pekonen F, Mäkinen T (1988) Soluble 34k binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: Evidence for autocrine/paracrine regulation of growth factor action. J Clin Endocrinol Metab 66: 173-180.
6. Frost RA, Mazella J, Tseng L (1993) Insulin-like growth factor binding protein-1 inhibits the mitogenic effect of insulin-like growth factors and progestines in human endometrial stromal cells. Biol Reprod 49: 104-111.
7. Wüster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R (1993) Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Int Med 234: 249-255.
8. Lahti E, Knip M, Laatikainen TJ (1994) Plasma insulin-like growth factor I and its binding protein 1 and 3 in post menopausal patients with breast cancer receiving long term tamoxifen. Cancer 74: 618-624.
9. Rutanen E-M, Stenman B, Blum W, Karkkainen T, Lehtovirta P, Stenman U-H (1993) Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: Comparison of endometrial cancer patients with healthy controls. J Clin Endocrinol Metab 77: 199-204.
10. Daughaday WH, Mariz IK, Blethen SL (1980) Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites; A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 51: 781-788.
11. Daughaday WH, Parker KA, Borowsky S, Trivedi B, Kapadia M (1982) Measurement of somatomedin-related peptides in fetal, neonatal and maternal rat serum by insulin-like growth factor (IGF)-I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction. Endocrinology 110: 575-581.
12. Rutanen E-M, Kärkkäinen T, Lundqvist C, Pekonen F, Ritvos O, Tanner P, Welin M, Weber T (1988) Monoclonal antibodies to the 27-34K insulin-like growth factor binding protein. Biochem Biophys Res Commun 152: 208-215.
13. Rutanen E-M, Pekonen F, Kärkkäinen T (1993) Measurement of insulin-like growth factor binding protein-1 in cervical/vaginal secretions: Comparison with the ROM-check membrane immunoassay in the diagnosis of ruptured fetal membrane. Clin Chim Acta 214: 73-81.
14. Mohan S, Baylink D (1995) Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: Comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 80: 637-647.
15. Donahue LR, Hunter SJ, Sherblom AP, Rosen C (1990) Age-related changes in serum insulin-like growth factor-binding proteins in women. J Clin Endocrinol Metab 71: 575-579.
16. Poehlman ET, Copeland KC (1990) Influence of physical activity on insulin-like growth factor-I in healthy younger and old men. J Clin Endocrinol Metab 71: 1468-1473.
17. Yamamoto H, Sohmiya M, Oka N, Kato Y (1991) Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinol 124: 487-500.
18. Romagnoli E, Minisola S, Carnevale V, Scarda A, Rosso R, Scarnecchi L, Pacitti MT, Mazzuoli G (1993) Effects of estrogen deficiency on IGF-I plasma levels: Relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 53: 1-6.
19. Weissberger AJ, Ho KKY, Lazarus L (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72: 374-381.
20. Giudice LC, Dsupin BA, Jin IH, Vu TH, Hoffman AR (1993) Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J Clin Endocrinol Metab 76: 1115-1122.
21. Kleinman D, Karas M, Roberts CTJr, LeRoith D, Phillip M, Segev Y, Levy J, Sharoni Y (1995) Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol. Endocrinology 136: 2531-2537.
22. Rutanen E-M, Nyman T, Lehtovirta P, Ämmälä M, Pekonen F (1994) Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: A molecular mechanism associating endometrial cancer with its risk factors. Int J Cancer 59: 307-312.